J Cancer 2017; 8(16):3130. doi:10.7150/jca.22507 This issue Cite

Erratum

Retraction: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma

Ruichao Chen1*, Minfeng Zhang1*, Qiulian Li1,5*, Hanzhen Xiong1, Shaoyan Liu1, Weiyi Fang3, Qianbing Zhang3, Zhen Liu1,2 Corresponding address, Xuehu Xu4 Corresponding address, Qingping Jiang1 Corresponding address

1. Department of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510150, PR, China;
2. Department of Pathology, Basic school, Guangzhou Medical University, Guangzhou,510000, PR China;
3. Cancer Research Institute, Southern Medical University, Guangzhou, 510515, PR China;
4. Gastrointestinal Department, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510150, PR, China;
5. Department of obstetrics and gynecology, First affiliated hospital, Gannan medical university, Gannan,341000, PR, China.
* These authors contributed equally to this work.

Citation:
Chen R, Zhang M, Li Q, Xiong H, Liu S, Fang W, Zhang Q, Liu Z, Xu X, Jiang Q. Retraction: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma. J Cancer 2017; 8(16):3130. doi:10.7150/jca.22507. https://www.jcancer.org/v08p3130.htm
Other styles

File import instruction

Retracted-article in J Cancer, Volume 8, 305

 

The authors have requested to retract this article, since in the lately repeated and further experiments they found MAP3K5 maybe not the true target gene of miR-BART22.

Author contact

Corresponding address Corresponding authors: Qingping Jiang:jiangqingpingedu.cn; Xuehu Xu: maxtigercom; Zhen Liu:narcissus_janecom.


Published 2017-9-8


Citation styles

APA
Chen, R., Zhang, M., Li, Q., Xiong, H., Liu, S., Fang, W., Zhang, Q., Liu, Z., Xu, X., Jiang, Q. (2017). Retraction: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma. Journal of Cancer, 8(16), 3130. https://doi.org/10.7150/jca.22507.

ACS
Chen, R.; Zhang, M.; Li, Q.; Xiong, H.; Liu, S.; Fang, W.; Zhang, Q.; Liu, Z.; Xu, X.; Jiang, Q. Retraction: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma. J. Cancer 2017, 8 (16), 3130. DOI: 10.7150/jca.22507.

NLM
Chen R, Zhang M, Li Q, Xiong H, Liu S, Fang W, Zhang Q, Liu Z, Xu X, Jiang Q. Retraction: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma. J Cancer 2017; 8(16):3130. doi:10.7150/jca.22507. https://www.jcancer.org/v08p3130.htm

CSE
Chen R, Zhang M, Li Q, Xiong H, Liu S, Fang W, Zhang Q, Liu Z, Xu X, Jiang Q. 2017. Retraction: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma. J Cancer. 8(16):3130.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image